Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3701
Vox Royalty Corp
VOXR
$334M
| $301K | ﹤0.01% |
60,012
+40,394
| +206% | +$205K |
2025 Q2
5 quarters
|
|
3702
Global X Silver Miners ETF NEW
SIL
$3.9B
| $301K | ﹤0.01% |
+3,500
| New | +$305K |
2026 Q3
0 quarters
|
|
3703
Driven Brands
DRVN
$1.99B
| $299K | ﹤0.01% |
25,294
-82,225
| -76% | -$1.11M |
2022 Q1
18 quarters
|
|
3704
Clearfield
CLFD
$420M
| $297K | ﹤0.01% |
9,543
-7,854
| -45% | -$239K |
2016 Q2
41 quarters
|
|
3705
Gran Tierra Energy
GTE
$341M
| $296K | ﹤0.01% |
30,009
-304
| -1% | -$2.64K |
2022 Q2
17 quarters
|
|
3706
HealthStream
HSTM
$887M
| $296K | ﹤0.01% |
9,953
+6,294
| +172% | +$181K |
2016 Q2
41 quarters
|
|
3707
Patria Investments
PAX
$1.57B
| $296K | ﹤0.01% |
29,117
+16,464
| +130% | +$181K |
2023 Q2
13 quarters
|
|
3708
PUT
Medtronic
MDT
$130B
| $293K | ﹤0.01% |
+3,400
| New | +$300K |
2026 Q3
0 quarters
|
|
3709
Almonty Industries
ALM
$2.37B
| $293K | ﹤0.01% |
22,265
-241,605
| -92% | -$3.63M |
2025 Q3
4 quarters
|
|
3710
Achieve Life Sciences
ACHV
| $293K | ﹤0.01% |
36,217
+16,223
| +81% | +$116K |
2024 Q2
9 quarters
|
|
3711
Angel Studios
ANGX
$794M
| $291K | ﹤0.01% |
62,410
+52,903
| +556% | +$234K |
2026 Q1
2 quarters
|
|
3712
CALL
Helus Pharma Inc. Common Stock
HELP
$684M
| $291K | ﹤0.01% |
+23,700
| New | +$248K |
2026 Q3
0 quarters
|
|
3713
Cardinal Infrastructure Group
CDNL
$316M
| $289K | ﹤0.01% |
9,444
+6,659
| +239% | +$332K |
2025 Q4
3 quarters
|
|
3714
Hyliion Holdings
HYLN
$509M
| $289K | ﹤0.01% |
69,298
+19,683
| +40% | +$76.1K |
2022 Q1
18 quarters
|
|
3715
PUT
Corcept Therapeutics
CORT
$8B
| $288K | ﹤0.01% |
2,500
| – | – |
2024 Q3
8 quarters
|
|
3716
MarketAxess Holdings
MKTX
$5.82B
| $288K | ﹤0.01% |
1,757
-19,742
| -92% | -$2.93M |
2013 Q2
53 quarters
|
|
3717
Titan Machinery
TITN
$569M
| $287K | ﹤0.01% |
12,452
+5,727
| +85% | +$117K |
2013 Q2
53 quarters
|
|
3718
Geron
GERN
$644M
| $287K | ﹤0.01% |
233,483
+118,243
| +103% | +$169K |
2013 Q2
53 quarters
|
|
3719
Ready Capital
RC
$150M
| $286K | ﹤0.01% |
246,794
+55,816
| +29% | +$91.3K |
2017 Q1
38 quarters
|
|
3720
indie Semiconductor
INDI
$558M
| $286K | ﹤0.01% |
97,759
+37,324
| +62% | +$138K |
2022 Q1
18 quarters
|
|
3721
Waterstone Financial
WSBF
$362M
| $285K | ﹤0.01% |
14,519
+5,357
| +58% | +$110K |
2016 Q1
42 quarters
|
|
3722
CALL
Insmed
INSM
$26.3B
| $285K | ﹤0.01% |
2,500
| – | – |
2026 Q2
1 quarter
|
|
3723
Hanover Bancorp
HNVR
$155M
| $283K | ﹤0.01% |
11,363
-905
| -7% | -$23.6K |
2024 Q3
8 quarters
|
|
3724
QuidelOrtho
QDEL
$809M
| $282K | ﹤0.01% |
26,732
+16,334
| +157% | +$240K |
2013 Q2
53 quarters
|
|
3725
First Capital
FCAP
$214M
| $281K | ﹤0.01% |
4,565
+846
| +23% | +$53K |
2019 Q2
29 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.